An Intervention to Reduce Sedentary Behavior for Black Adults With Chronic Kidney Disease

Not Applicable

Recruiting

• Conditions: Chronic Kidney Disease(CKD)

• Registration Number: NCT06754280
• Lead Sponsor: University of Illinois at Chicago

Brief Summary

RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-12-23
• Study First Submitted QC: 2024-12-23
• Study First Posted: 2024-12-31
• Status Verified: 2025-04
• Study Start: 2025-04-17
• Last Update Submitted: 2025-04-29
• Last Update Posted: 2025-05-01
• Primary Completion: 2026-09
• Study Completion: 2027-05

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Self-identifies as Black or African American
• Age ≥35 to ≤80 years old
• CKD Stage 1-4
• Self-reported 6 or more hours/day of sedentary time
• Ability to speak/read/understand English
• Has access to a telephone

Exclusion Criteria

• Being unable to walk 1 block
• Being unable to stand from a seated position without assistance
• Using a wheelchair, walker, or cane for all of their ambulation
• Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
• Kidney transplant
• Any other condition that the investigator considers precludes participation in the trial
• Participated in the Patient Advisory Board

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in sedentary time	Baseline to week 12	Change in activPAL-measured sedentary time

Secondary Outcome Measures

Name	Time	Method
Change in self-reported sedentary time	Baseline to week 12	Change in self-reported sedentary time
Change in health-related quality of life	Baseline to week 12	Change in health-related quality of life measured via the KDQOL

Trial Locations

Locations (1)

UI Health/University of Illinois Chicago; 🇺🇸 Chicago, Illinois, United States